![Ramzi Amri](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profiel
Ramzi Amri is currently Chief Financial Officer at Oncoinvent ASA starting in 2026.
Formerly, Dr. Amri was VP, Head-Development Strategy & Execution at Galapagos NV.
Education includes a doctorate from the University of Amsterdam.
Actieve functies van Ramzi Amri
| Bedrijven | Functie | Begin |
|---|---|---|
| ONCOINVENT ASA | Financieel Directeur/CFO | 15-01-2026 |
Eerdere bekende functies van Ramzi Amri
| Bedrijven | Functie | Einde |
|---|---|---|
| LAKEFRONT BIOTHERAPEUTICS NV | Corporate Officer/Principal | - |
Opleiding van Ramzi Amri
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Bedrijven in privébezit | 3 |
|---|---|
Galapagos NV
 Galapagos NV BiotechnologyHealth Technology Manufactures and develops pharmaceutical products for oncology | Health Technology |
University of Amsterdam
 University of Amsterdam Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
BerGenBio ASA
 BerGenBio ASA Pharmaceuticals: MajorHealth Technology Develops drugs for aggressive, drug resistant cancers | Health Technology |
